Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ptc Therapeutics (PTCT) Inventory Average (2017 - 2025)

Historic Inventory Average for Ptc Therapeutics (PTCT) over the last 9 years, with Q3 2025 value amounting to $43.4 million.

  • Ptc Therapeutics' Inventory Average rose 2852.27% to $43.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.4 million, marking a year-over-year increase of 2852.27%. This contributed to the annual value of $26.9 million for FY2024, which is 264.58% up from last year.
  • Per Ptc Therapeutics' latest filing, its Inventory Average stood at $43.4 million for Q3 2025, which was up 2852.27% from $27.9 million recorded in Q2 2025.
  • Ptc Therapeutics' Inventory Average's 5-year high stood at $43.4 million during Q3 2025, with a 5-year trough of $14.9 million in Q3 2022.
  • In the last 5 years, Ptc Therapeutics' Inventory Average had a median value of $24.2 million in 2023 and averaged $24.6 million.
  • Per our database at Business Quant, Ptc Therapeutics' Inventory Average soared by 12729.41% in 2023 and then crashed by 2600.15% in 2025.
  • Quarter analysis of 5 years shows Ptc Therapeutics' Inventory Average stood at $15.7 million in 2021, then rose by 16.37% to $18.3 million in 2022, then soared by 81.13% to $33.2 million in 2023, then decreased by 11.25% to $29.4 million in 2024, then soared by 47.37% to $43.4 million in 2025.
  • Its Inventory Average was $43.4 million in Q3 2025, compared to $27.9 million in Q2 2025 and $22.4 million in Q1 2025.